Skip to main content
COO logo

COO · Cooper Companies, Inc. · Earnings Call Transcripts & Audio

Track COO — free
$56.53 -0.10 (-0.18%) At close · Sep 30
Market Cap
$10.86B
Shares
190.16M
Volume · Sep 30 4.9M Avg daily vol (3M) 3.05M

Cooper Companies, Inc. Earnings Call Transcripts

Quarterly earnings calls for Cooper Companies, Inc. (COO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Earnings call
FY26 · Q3
2026-09-09
Cooper Companies, Inc. (COO) Q3 2026 Earnings Call Transcript
Positive tone Sales force expansion Cooper Surgical (CSI) portfolio review EMR&D market contrast
Revenue
$1.07B
▲ 0.6% YoY
Diluted EPS
$2.24
▲ 357.1% YoY
Gross margin
66.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-06-04
Cooper Companies, Inc. (COO) Q2 2026 Earnings Call Transcript
Confident tone Asia-Pacific Headwinds Cooper Vision / Americas & EMEA Growth Myopia Control (MiSight)
Revenue
$1.08B
▲ 7.9% YoY
Diluted EPS
$-0.40
▼ 190.9% YoY
Gross margin
68.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-03-05
Cooper Companies, Inc. (COO) Q1 2026 Earnings Call Transcript
Confident tone Raised guidance for earnings and free cash flow CooperVision market share and premium product growth Asia Pacific and Japan softness
Revenue
$1.02B
▲ 6.2% YoY
Diluted EPS
$0.66
▲ 26.9% YoY
Gross margin
67.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-04
Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript
Confident tone CooperVision market share and MyDay momentum Private label contract wins Product launches and pipeline
Revenue
$1.07B*
▲ 4.6% YoY
Gross margin
61.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-08-27
Cooper Companies, Inc. (COO) Q3 2025 Earnings Call Transcript
Positive tone MyDay growth and rollout Regional performance Margin and earnings execution
Revenue
$1.06B
▲ 5.7% YoY
Diluted EPS
$0.49
▼ 5.8% YoY
Gross margin
65.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-05-29
Cooper Companies, Inc. (COO) Q2 2025 Earnings Call Transcript
Positive tone CooperSurgical fertility softness, especially Asia Pac CooperVision contact lens growth Daily silicone hydrogel expansion and product launches
Revenue
$1.00B
▲ 6.3% YoY
Diluted EPS
$0.44
▲ 0% YoY
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-06
Cooper Companies, Inc. (COO) Q1 2025 Earnings Call Transcript
Confident tone CooperVision product portfolio and launches Margin and earnings performance Capacity expansion
Revenue
$964.70M
▲ 3.6% YoY
Diluted EPS
$0.52
▲ 26.8% YoY
Gross margin
68.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-05
Cooper Companies, Inc. (COO) Q4 2024 Earnings Call Transcript
Confident tone CooperVision Daily Silicone Hydrogel Growth (MyDay, clariti) MiSight Myopia Management Industry Shift to Dailies and Torics
Revenue
$1.02B*
▲ 9.8% YoY
Gross margin
66.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-08-28
Cooper Companies, Inc. (COO) Q3 2024 Earnings Call Transcript
Confident tone Daily Contact Lens Growth and Capacity Expansion CooperSurgical Record Revenues Myopia Management with MiSight
Revenue
$1.00B
▲ 7.8% YoY
Diluted EPS
$0.52
▲ 20.9% YoY
Gross margin
66.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-05-30
Cooper Companies, Inc. (COO) Q2 2024 Earnings Call Transcript
Confident tone CooperSurgical and PARAGARD Myopia Management with MiSight China and Ortho-K Headwinds
Revenue
$942.60M
▲ 7.4% YoY
Diluted EPS
$0.44
▲ 120% YoY
Gross margin
67.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-02-29
Cooper Companies, Inc. (COO) Q1 2024 Earnings Call Transcript
Confident tone MyDay Daily Silicone Hydrogel Portfolio CooperSurgical and Fertility Business Myopia Management and MiSight
Revenue
$931.60M
▲ 8.5% YoY
Diluted EPS
$0.41
▼ 4.7% YoY
Gross margin
67.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-07
Cooper Companies, Inc. (COO) Q4 2023 Earnings Call Transcript
Revenue
$927.10M*
▲ 9.3% YoY
Gross margin
65.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-08-30
Cooper Companies, Inc. (COO) Q3 2023 Earnings Call Transcript
Revenue
$930.20M
▲ 10.3% YoY
Diluted EPS
$0.43
▼ 13.1% YoY
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-01
Cooper Companies, Inc. (COO) Q2 2023 Earnings Call Transcript
Revenue
$877.40M
▲ 5.7% YoY
Diluted EPS
$0.20
▼ 68.6% YoY
Gross margin
66.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-02
Cooper Companies, Inc. (COO) Q1 2023 Earnings Call Transcript
Revenue
$858.50M
▲ 9.1% YoY
Diluted EPS
$0.43
▼ 9.9% YoY
Gross margin
65.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-08
Cooper Companies, Inc. (COO) Q4 2022 Earnings Call Transcript
Revenue
$848.00M*
▲ 11.7% YoY
Gross margin
63.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-08-31
Cooper Companies, Inc. (COO) Q3 2022 Earnings Call Transcript
Revenue
$843.40M
▲ 10.5% YoY
Diluted EPS
$0.50
▼ 84% YoY
Gross margin
65.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-02
Cooper Companies, Inc. (COO) Q2 2022 Earnings Call Transcript
Revenue
$829.80M
▲ 15.3% YoY
Diluted EPS
$0.64
▲ 8.1% YoY
Gross margin
64.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-03
Cooper Companies, Inc. (COO) Q1 2022 Earnings Call Transcript
Revenue
$787.20M
▲ 15.7% YoY
Diluted EPS
$0.48
▼ 95.5% YoY
Gross margin
65.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-02
Cooper Companies, Inc. (COO) Q4 2021 Earnings Call Transcript
Revenue
$759.10M*
▲ 11.4% YoY
Gross margin
66.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-02
Cooper Companies, Inc. (COO) Q3 2021 Earnings Call Transcript
Revenue
$763.40M
▲ 32% YoY
Diluted EPS
$3.09
▲ 1004.5% YoY
Gross margin
67.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-03
Cooper Companies, Inc. (COO) Q2 2021 Earnings Call Transcript
Revenue
$719.50M
▲ 37.1% YoY
Diluted EPS
$0.59
▲ 926.1% YoY
Gross margin
67.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-04
Cooper Companies, Inc. (COO) Q1 2021 Earnings Call Transcript
Revenue
$680.50M
▲ 5.3% YoY
Diluted EPS
$10.58
▲ 2224.7% YoY
Gross margin
66.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-03
Cooper Companies, Inc. (COO) Q4 2020 Earnings Call Transcript
Revenue
$681.60M
▼ 1.4% YoY
Diluted EPS
$0.41
▼ 32.2% YoY
Gross margin
62.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-03
Cooper Companies, Inc. (COO) Q3 2020 Earnings Call Transcript
Revenue
$578.20M
▼ 14.9% YoY
Diluted EPS
$0.28
▼ 53.3% YoY
Gross margin
62.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-04
Cooper Companies, Inc. (COO) Q2 2020 Earnings Call Transcript
Revenue
$524.90M
▼ 19.8% YoY
Diluted EPS
$0.06
▼ 90.6% YoY
Gross margin
61.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-05
Cooper Companies, Inc. (COO) Q1 2020 Earnings Call Transcript
Revenue
$646.20M
▲ 2.9% YoY
Diluted EPS
$0.46
▼ 12.1% YoY
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–27 of 27 earnings calls
Key facts CIK 711404 CUSIP 216648501 13F (30d) 18 filings 14 filers Visit website Investor relations